SPI ex SLI

SPI ex SLI handeln

5.572,23 PKT -19,00 PKT -0,34 %

23.09.26

Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

ISIN CH0033051423

Analysen zu SPI ex SLI-Werten

Datum	Rating	Analyst
27.01.05	Kudelski Buy	Helvea
26.01.05	ARYZTA Neutral	Sarasin Research
25.01.05	OC Oerlikon Reduce	Sarasin Research
24.01.05	Komax Neutral	Helvea
25.01.05	mobilezone Market Outperform	Vontobel
24.01.05	Komax Neutral	Sarasin Research
21.01.05	Sulzer Buy	Helvea
21.01.05	Komax Buy	Sarasin Research
21.01.05	Ascom Market Outperform	Vontobel
21.01.05	ARYZTA Buy	Helvea
21.01.05	Rieter Buy	Helvea
21.01.05	Sulzer Buy	Helvea
20.01.05	ARYZTA Neutral	Sarasin Research
19.01.05	BB Biotech Kaufen	Hamburger Sparkasse
19.01.05	Clariant Halten	Helaba Trust
19.01.05	Barry Callebaut Neutral	Helvea
21.01.05	Clariant Kaufen	Helaba Trust
19.01.05	Tecan (N) Reduce	Helvea
19.01.05	OC Oerlikon Buy	Helvea
19.01.05	OC Oerlikon Neutral	Sarasin Research
19.01.05	OC Oerlikon Accumulate	Helvea
20.01.05	Rieter Buy	Helvea
19.01.05	Komax Neutral	Helvea
18.01.05	OC Oerlikon Buy	Helvea
18.01.05	Siegfried Neutral	Helvea
18.01.05	Sulzer Buy	Sarasin Research
20.01.05	OC Oerlikon Accumulate	Helvea
24.01.05	Helvetia Baloise Reduce	Sal. Oppenheim
18.01.05	Swiss Prime Site Neutral	Helvea
20.01.05	Sulzer Buy	Helvea
20.01.05	Helvetia Baloise Outperform	Goldman Sachs
18.01.05	Swiss Prime Site Neutral	Helvea
18.01.05	INFICON Buy	Sarasin Research
14.01.05	Clariant Outperform	HypoVereinsbank
17.01.05	Swiss Prime Site Neutral	Sarasin Research
14.01.05	Rieter Neutral	Credit Suisse First Boston
17.01.05	Tecan (N) Neutral	Credit Suisse First Boston
17.01.05	Basilea Pharmaceutica Outperform	Credit Suisse First Boston
13.01.05	Sulzer Buy	Sarasin Research